HostDx Sepsis in the Diagnosis and Prognosis of Emergency Department Patients with Suspected Infections (SEPSIS-SHIELD)

Grants and Contracts Details

StatusFinished
Effective start/end date1/16/20 → 3/1/22

Funding

  • Inflammatix Incorporated: $36,488.00